Skip to NavigationSkip to content

News

The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave the European Union...
Patients on the NHS in England and Wales will now be able to access Amgen’s Blincyto  after NICE reveals it has chosen to recommend the drug...
The biopharmaceutical contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 10.6% between 2017 and 2027,...
MSD has revealed that Keytruda has been awarded marketing authorisation from the FDA as a monotherapy in the treatment of metastatic small cell...
A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5...
The FDA has said that it is expanding a database used by generic drugmakers to get information on when their products can be marketed and approved.
AstraZeneca and MSD’s jointly-developed therapy Lynparza (olaparib) has scored its third EU approval, the pair announced, with authorisation for...
Roche’s personalised cancer therapy Rozlytrek (entrectinib) has seen its first approval: the drug has been approved in Japan for the treatment of...
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a recall of M&A Pharmachem’s 500mg paracetamol tablets.
The FDA has approved Novo Nordisk’s Victoza (liraglutide) for paediatric patients aged 10 years and older with type 2 diabetes.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches